×
0 0 0 0.00683850604944761 -0.000526038926880671 0.00263545502367178 0.00210415570752231 -0.000526038926880671
Stockreport

Deciphera Pharmaceuticals, Inc. to Report Clinical Data with DCC-2618 at the Upcoming 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

DECIPHERA PHARMACEUTICALS (DCPH)  More Company Research Source: GlobeNewswire
US:NASDAQ Investor Relations: deciphera.com/investor-relations
PDF WALTHAM, Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced that an abstract highlighting the company’s pan-KIT and PDGFRa inhibitor, DCC-2618 in patients with malignant gliomas, has been selected for a poster presentation at the 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) November 16-19, 2017 in San Francisco, CA. Details for the poster are as follows: Title: DCC-2618, a novel pan-KIT and PDGFRa kinase switch control inhibitor, shows encouraging signal in a patient (pt) with glioblastoma (GBM)Author: John de Groot M.D., Department of Neuro-Oncology at The University of Texas MD Anderson Cancer CenterAbstract #: 14730­­­Date: Saturday, November 18, 2017, 5 – 7 pm. About DCC-2618DCC-2618 is currently in a first-in-human Phase 1 clinical trial. DCC-2618 is a pan-KIT and PDGFRa kinas [Read more]

IMPACT SNAPSHOT EVENT TIME: DCPH
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS